Project Details
Description
A 2-year, randomized, double-blind, placebo-controlled phase 3 study to evaluate the long-term efficacy and safety of cp-945,598 in the treatment of obese subjects
| Status | Finished |
|---|---|
| Effective start/end date | 10/5/06 → 10/31/09 |
Funding
- PFIZER, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.